Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

While no statistically significant difference was observed in the cumulative recurrence rates between the GCs group and the GCs + EBD group at the 1 st, 3rd, 6th, and 12th months after treatment ( P = 0.36, 0.96, 0.78, and 0.28, respectively), the GCs + EBD group showed a trend toward lower recurrence rates at all these time points.
Consensus clustering of immune cell proportions classified BCa samples into four distinct subtypes (C1-C4), with differential risk group distributions: C1 (wound healing), C3 (inflammatory), and C4 (lymphocyte-depleted) subtypes were relatively more common in low-risk cases, while the C2 (IFN-γ-dominant) subtype showed a trend toward higher prevalence in high-risk patients, though this association did not reach statistical significance (Fig. 4 E).
In the deep brain regions, where IT delivery has struggled to demonstrate significant RNA KD in other large animal models, 9 , 11 ICV delivery resulted in significantly enhanced KD in the caudate and showed a trend toward more KD in the thalamus that did not reach statistical significance ( Figure 7 B).
The integration of the risk model constructed by HGRGs yielded a numerically higher, but not statistically significant, C-index (0.769, 95% CI: 0.734–0.804) and showed a trend toward improved discriminative ability versus omitting it (C-index = 0.759, 95% CI: 0.723–0.795) ( Figure 7d and e ). 3.5 Enrichment analysis KEGG enrichment analysis identified several functions associated with the five HGRGs, including glycolysis/gluconeogenesis, carbon metabolism, etc.
Lathosterol showed a trend toward greater lowering in patients with higher LDL-C at baseline, and the XR 0.8 mg/day group was associated with significantly greater lathosterol lowering than the IR 0.2 mg/day group, with the exception of the LDL-C ≥ 160 mg/dL subgroup. β-Sitosterol and campesterol showed a trend toward greater lowering in patients with higher LDL-C at baseline, but there was no statistical difference in the percentage change among the treatment groups.